Form4.ai tracks every SEC insider trade in real time. See every ESLA insider filing with a free account — no card.
See every ESLA insider filing — free account, no card.
Free accountEstrella Immunopharma, Inc. (ESLA) has 3 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Nov. 4, 2026.
Open-market value, last 90 days
No open-market buys or sales in this period.
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Aug 26, 2026 SEC filing | Liu Cheng CEO | Option exercise | $81,500 | — |
| Aug 25, 2026 SEC filing | Xu Jiandong Chief Financial Officer | Option exercise | $81,500 | — |
Create a free account to see all 3 ESLA filings from the last 90 days. No card needed.
Create free accountWant ESLA insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.